A CMS international team has advised 21 Invest and Ardian on the sale of Synerlab, European leader in pharmaceutical development and manufacturing, to the US investment fund Blue Wolf Capital Partners. CMS Spain‘s advice focused mainly on the structuring and preparation of the documentation related to the acquisition of the Spanish subsidiary Laboratorios Alcalá Farma.
The transaction has been led in Spain by our partner, Mariano Bautista, and senior lawyer, Jorge Peris, both from the corporate department (both pictured). Paula Zafra and Itziar Martínez-Pardo, commercial lawyers; Juan Moreno, Ana Doval and Alejandro García-Noblejas, partner and lawyers of public law and regulated sectors respectively; Irene San Martín and Lucía Signes, lawyers of intellectualproperty and digital business and Ricardo Héctor, Marta Burgos and Isabel Montes, partner and lawyers of tax.
On behalf of CMS France, the office that led the global operation, the following participated: Arnaud Hugot, partner, Matthieu Rollin and Louise Paysant, lawyers, on corporate/M&A aspects, Philippe Gosset, partner, Maÿlis Motte and Thomas Louvel, tax lawyers, Caroline Froger-Michon, partner, and Camille Baumgarten, lawyer, for labor law aspects, Guillaume Melot, lawyer, for foreign investment aspects, Alexandre Chazot, counsel, for financing aspects, and François Bossé-Cohic, counsel, and Inès Mzali, counsel, for advising the management team.
Natixis Partners, KPMG and Roland Berger also participated alongside the selling partners. Blue Wolf Capital Partners was advised by Kirkland & Ellis LLP.
